Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Any compound that potentiates this pathway carries a theoretical risk of promoting neoplastic processes (PMID: 34179015) No Chronic Toxicity Data: Long-term effects of sustained HGF/c-Met potentiation are unstudied even in animal models Uncharacterized Dose-Response: The relationship between Dihexa dose and adverse effects in any living system is poorly defined beyond acute preclinical studies No Regulatory Review: Dihexa has never undergone the systematic safety evaluation required for regulatory submission Safety Comparison Summary: Cerebrolysin has a known, well-characterized safety profile from decades of clinical use
Appetite reduction is one visible result, but the mechanism is broader
According to the Terms of Use, Xpedicare is "an independent professional entity solely responsible for providing clinical services and making all medical decisions." Providers are independently contracted or employed by Xpedicare - not by MadeMed
Common side effects, when they occur, are typically mild and transient
Any use outside legitimate scientific research is prohibited
US$ 28.71
US$ 25.25
US$ 28.85
US$ 25.12
